galactosamine has been researched along with esculetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadota, S; Ketut, AI; Nagaoka, T; Tezuka, Y; Wu, LJ; Xiang, T; Xiong, QB | 1 |
| Baluchnejadmojarad, T; Mohamadi-Zarch, SM; Nazari-Serenjeh, M; Nourabadi, D; Ramazi, S; Roghani, M | 1 |
2 other study(ies) available for galactosamine and esculetin
| Article | Year |
|---|---|
Studies on the hepatocyte protective activity and the structure-activity relationships of quinic acid and caffeic acid derivatives from the flower buds of Lonicera bournei.
Topics: Animals; Apoptosis; Caffeic Acids; Cells, Cultured; Drugs, Chinese Herbal; Ethers; Galactosamine; Glycosides; Hepatocytes; In Vitro Techniques; Inositol; Liver; Magnetic Resonance Spectroscopy; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred Strains; Molecular Structure; Plants, Medicinal; Quinic Acid; Spectrophotometry, Infrared; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Umbelliferones | 2001 |
Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice.
Topics: Animals; Disease Models, Animal; Galactosamine; Interleukin-1beta; Interleukin-6; Iran; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Protective Factors; Toll-Like Receptor 4; Umbelliferones | 2021 |